Automatic Milking System (AMS) installations are increasing in the USA despite the higher investment cost than conventional systems. Surveys on AMSs conducted outside the USA focused on small–medium herds, specific regions, or aspects of AMS milking. This study described farmers’ perceptions about the decision-making process of adopting an AMS in the USA’s large dairies (≥7 AMS boxes) regarding changes in technology, housing, management practices, labor, herd performance, and health. After being contacted, 27 of 55 farmers from large AMS herds completed the survey. The main reasons for adopting an AMS were labor costs, cows’ welfare, and herd performance. Most farms constructed new barns, used a free-flow traffic system, and changed their feed management. Increases in water and energy use were perceived by 42% and 62% of farmers, respectively. Farmers estimated decreases in labor costs of over 21%, and AMS employees worked 40–60 h/week. Milk production increases were reported by 58%, with 32% observing higher milk fat and protein content. Easier sick cow detection, better mastitis management, and improvements in pregnancy rates were reported. Thus, farmers transitioning to AMSs perceived altered resource utilization, labor cost savings, and improvements in employee quality of life, animal welfare, and farm management. While 54% of respondents would recommend an AMS to other farms, 38% suggested considering additional aspects prior to adoption.

Automatic milking system (AMS) adoption in the United States is trending upward, with issues such as lower availability and increased cost of labor being factors frequently listed as motives for AMS implementation. In addition, more interest in precision dairy farming by the new generation of farmers may also help increase AMS adoption. The objective of this scoping review was to characterize the nature of the literature investigating non-pasture-based AMS and the opportunities and challenges for future research. The eligibility criteria included studies published in or after the year 2000, with full text in English, of at least 500 words, examining various outcomes related to AMS in non-pasture-based dairy farms. Six electronic databases were searched: Biosis (Web of Science), CAB Abstracts (CAB Direct), Medline (PubMed), PubAg, AGRIS (FAO), and Scopus (Elsevier). The review focused on studies with objectives, characteristics, farms, and AMS information. A total of 4,292 titles and abstracts were screened, and 536 studies were finally included. Most of the studies were conducted in Europe (73.5%), among commercial herds (67.9%), comprising Holstein cows (57.7%), using Lely and DeLaval brands (45.4% vs. 39.7%), with free-flow traffic (52.7%). The main research topics investigated were milk production, milk composition, and AMS efficiency, followed by behavior and welfare, health disorders (especially mastitis), and nutrition in Europe and other regions. At the same time, in the United States, trends were similar, except for nutrition. Since 2016 there has been an increased interest in studies on energy and water consumption, technological development, environment (enteric emissions), reproduction, genetics, and longevity or culling. However, the small number of studies and unclear characterization of what is optimum for reproductive management, other health disorders, economics, and water and energy consumption suggest a need for future research.

A study was conducted at 3 commercial dairies in California to compare outcomes of treating nonsevere (mild and moderate) gram-negative (GN) clinical mastitis (CM) with intramammary (IMM) ceftiofur HCl (125 mg of ceftiofur HCl per tube) in either 2-d (SP2) or 5-d (SP5) treatment programs compared with nontreatment (CON). In addition, we contrasted results from cases classified as mild and moderate. Four hundred fifteen cases were included in the final dataset, including 135 CON, 133 SP2, and 147 SP5. Milk from quarters with CM was sampled for on-farm culture (OFC) to differentiate gram-positive (GP) and GN bacteria, with results known within 24 h. Those with GN infections were randomly assigned to experimental groups, while those with GP, mixed infections, and contaminated samples did not continue in the study and received standard farm therapy. For cows with GN infections, a sample was submitted for MALDI-TOF assay. Only nonsevere cases were enrolled, and all quarters yielded monocultures of GN species. Clinical scores were obtained 0, 1, 2, 3, 4, 5, 14, 21, and 28 ± 3 d relative to enrollment. Milk samples were collected from quarters 14, 21, and 28 ± 3 d after enrollment, and submitted for routine culture and, when appropriate, submitted to MALDI-TOF evaluation. For many response criteria, there were significant interactions between treatments and CM severity scores at the time of enrollment, with effectiveness of ceftiofur HCl treatment being more beneficial compared with CON as mastitis clinical severity increased. While most treatment responses were significant for animals with mild or moderate GN mastitis, the largest responses were noted among cows with moderate CM cases.

On 3 large California dairies, 415 lactating cows with nonsevere clinical mastitis (CM) and infected with gram-negative (GN) bacteria were randomly assigned to 1 of 3 treatment groups: nontreated control (CON; 135 cases), 2 d of ceftiofur HCl (SP2; 133 cases), or 5 d of ceftiofur HCl (SP5; 147 cases). Bacteriological cure, clinical cure, mastitis recurrence, culling or death, and overall treatment success differed among treatment groups. Although duration of milk withheld due to mastitis therapy was higher for SP5 (9.4 d), there was no difference between CON (6.9 d) and SP2 (7.1 d). Culling and death rates due to GN CM were the main effects that affected partial cost calculations. Of study cows culled across the 3 herds, a higher proportion of CON cows (25%) were culled compared with SP2 (11%) or SP5 (18%). Mastitis-related expenses were higher ($550) for CON than SP2 ($343) or SP5 ($423). Results of this partial budget evaluation for the 3 California dairies indicated economic justification for treating cases of nonsevere GN CM with ceftiofur HCl for 2 d.

Bovine mastitis is a significant disease affecting dairy cattle worldwide, impacting milk quality and farm profitability. Understanding pathogen distribution is crucial for effective disease management. This study analyzed 319,634 individual cow milk samples submitted to the UC Davis Milk Quality Laboratory between 2009 and 2023 to assess pathogen prevalence, seasonal variations, and long-term trends. Routine microbiological cultures identified major and minor mastitis pathogens, with additional testing for Mycoplasma spp. Statistical analyses evaluated annual and seasonal trends in bacterial isolation rates. Results indicated that environmental pathogens, particularly non-aureus staphylococci and coliforms, were most frequently isolated, while contagious pathogens (Staphylococcus aureus, Streptococcus agalactiae, and Mycoplasma spp.) were less prevalent. Seasonal trends revealed higher contamination rates in Winter and increased no-growth samples in Summer. The study also observed a decline in sample submissions in recent years, possibly reflecting evolving dairy management practices. These findings provide a comprehensive perspective on mastitis pathogen dynamics in California’s Central Valley, supporting improved milk quality control measures and tailored mastitis prevention strategies.